Al-Kindi Company for the Production of Veterinary Vaccines and Medicines has submitted its financial statements for the second quarter of 2026 to the Commission, in compliance with ISX financial disclosure requirements.

Al-Kindi Company for the Production of Veterinary Vaccines and Medicines has submitted its financial statements for the second quarter of 2026 to the Commission, in compliance with ISX financial disclosure requirements.